Facebook
Twitter
LinkedIn
ForwardRicardo Gonzalez, MD
Dr. Ricardo R. Gonzalez is an internationally-recognized expert in minimally-invasive treatments for voiding dysfunction. For men, he is an expert in surgical therapies for BPH, including GreenLight laser vaporization of the prostate, enucleation, Rezum, Urolift, Aquablation and others. He has been invited to teach laser surgery throughout the U.S. and in 17 foreign countries. His research includes the development and evaluation of minimally invasive treatments that improve voiding function in men while preserving sexual function. His focus also encompasses the evaluation and management in urinary incontinence and pelvic floor reconstruction and functional restoration in women.
He strives to provide state-of-the-art urologic care to improve patients’ quality of life, especially with urinary and sexual function.
Dr. Gonzalez was the former Medical Director for the Centers for Voiding Dysfunction and Clinical Research at Houston Metro Urology. He has joined the full-time faculty at Houston Methodist Hospital with faculty affiliations at Weil Cornell and Baylor College of Medicine. He is a graduate of Stanford University School of Medicine and completed his residency and fellowship at Cornell in New York City. He currently practices urology with a focus on voiding dysfunction and pelvic restorative medicine reconstructive surgery in The Texas Medical Center in Houston, TX.
He is a diplomate of the American Board of Urology (ABU) and has earned board subspecialty certification in female pelvic medicine and reconstructive surgery (FPMRS).
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Medeon BioDate added:Date updated:07/07/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:ColoplastDate added:Date updated:07/07/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Tiumed, LLCDate added:Date updated:07/07/2022
-
Attribution:SelfType of financial relationship:StockIneligible company:Procept BioroboticsDate added:Date updated:07/07/2022
-
Attribution:SelfType of financial relationship:OtherIneligible company:American Urological AssociationDate added:Date updated:07/07/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Boston ScientificDate added:Date updated:07/07/2022
-
Attribution:SelfType of financial relationship:OtherIneligible company:AllerganDate added:Date updated:07/07/2022